News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Elvina Almuradova: Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
Elvina Almuradova and Komal Jhaveri
Apr 9, 2025, 08:51

Elvina Almuradova: Imlunestrant with or without Abemaciclib in Advanced Breast Cancer

Elvina Almuradova, Ambassador at European School of Oncology, shared an article Komal Jhaveri and her colleagues authored on X:

“New in NEJM!!!

Imlunestrant shows promise in ER+/HER2- advanced breast cancer with ESR1 mutations – PFS 5.5 vs 3.8 months vs standard therapy. Adding Abemaciclib boosts PFS to 9.4 months.”

Imlunestrant with or without Abemaciclib in Advanced Breast Cancer

Authors: Komal L. Jhaveri et al.

Elvina Almuradova

Imlunestrant and Abemaciclib: A Study in Advanced Breast Cancer
André Mattar Antonio Llombart-Cussac Breast Cancer cancer Chih-Chiang Hung Chiun-Sheng Huang Christoph Cramer von Laue Cristina Saura Elgene Lim Emily Barrett Eriko Tokunaga François-Clément Bidard Giuseppe Curigliano Joohyuk Sohn Jorge Luis Martinez Rodriguez Joyce O'Shaughnessy Kamnesh R. Pradhan Komal L. Jhaveri Lillian M. Smyth Lisa A. Carey Manuel Ruiz Borrego María de la Luz García Tinoco Monica Lis Casalnuovo Nadia Harbeck OncoDaily Oncology Patrick Neven Philippe Aftimos Qingyuan Zhang Rikiya Nakamura Shanshan Cao Sung-Bae Kim Xuejing Aimee Wang
Special Coverage
Blog
May 9, 2025, 11:28
Tanja Obradovic Highlights Ivonescimab’s Phase III Entry in Pancreatic Cancer
Blog
May 9, 2025, 11:28
Dato' Dr Saunthari Somasundaram: I’m deeply honored to be elected as the next President-Elect of the NCD Alliance
Blog
May 9, 2025, 11:22
Amer Zeidan: Honoring Two Giants in MDS at the MDSF25 Biennial Meeting
Blog
May 9, 2025, 11:20
Ruben Mesa: Great Cancer Care Starts With Great Cancer Nursing
Blog
May 9, 2025, 11:19
National Cancer Institute of Kenya Raises Awareness on Melanoma Risks and Early Detection
Blog
May 9, 2025, 11:11
Jessie Dalman: Proud of Emily Barrett for Finishing Her Time as a Chief Resident
Opinion
May 9, 2025, 11:07
Bold Leadership and Vision: Why Dr. Narjust Florez Deserves Undesignated IASLC Board Seat #4 - Florez Lab
Blog
May 9, 2025, 11:01
Runcie C.W. Chidebe: Join Our Team at Devatop Centre for Africa Development
Blog
May 9, 2025, 10:56
City Cancer Challenge Expands Technical Partnerships to Strengthen Global Cancer Care
Opinion
May 9, 2025, 10:55
Jay Bhattacharya Halts NIH Lab Operations Over Biocontainment Breach
Blog
May 9, 2025, 10:50
Maria (Masha) Babak: Honored to Receive the College of Science Teaching Excellence Award
Blog
May 9, 2025, 10:42
BSMO Highlights Need for Sustainable Support in Belgium’s Precision Oncology Efforts